Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Chimeric 4/9ICR reprograms immunosuppressive IL-4 signals to enhance B7-H3-targeted CAR-T cell efficacy against triple-negative breast cancer.

Created on 19 Nov 2026

Authors

Renyi Ding, Cangang Zhang, Anjun Jiao, Zhao Feng, Shuo Liu, Yang Gao, Yifei Huang, Shuangyu Wei, Dan Zhang, Lina Sun, Chenming Sun, Baojun Zhang, Gang Wang, Hui Zhang

Published in

Journal for immunotherapy of cancer. Volume 14. Issue 11. Nov 18, 2026. Epub Nov 18, 2026.

PMID:
43051941
Bibliographic data and abstract were imported from PubMed on 19 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement